Published in Head Neck on November 01, 2001
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging (2011) 1.82
Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol (2009) 1.66
FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma. Imaging Med (2012) 1.32
Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma. J Cancer Res Clin Oncol (2009) 1.25
FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT. Eur J Nucl Med Mol Imaging (2004) 1.17
Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer. Int J Radiat Oncol Biol Phys (2010) 1.15
Glucose deprivation-induced metabolic oxidative stress and cancer therapy. J Cancer Res Ther (2009) 1.13
Imaging of sinonasal tumours. Cancer Imaging (2012) 1.10
The prognostic value of PET and PET/CT in cervical cancer. Cancer Imaging (2008) 1.10
Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer. Eur J Nucl Med Mol Imaging (2011) 1.09
Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer. J Oncol (2009) 1.06
FDG-PET staging and importance of lymph node SUV in head and neck cancer. Head Neck Oncol (2010) 1.03
Head and neck squamous cell carcinoma: usefulness of diffusion-weighted MR imaging in the prediction of a neoadjuvant therapeutic effect. Eur Radiol (2008) 0.99
Detecting recurrent laryngeal carcinoma after radiotherapy: room for improvement. Eur Arch Otorhinolaryngol (2003) 0.99
Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancer. Int J Cancer (2013) 0.96
Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy. PLoS One (2013) 0.94
The cost-effectiveness of 18FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy. Eur Arch Otorhinolaryngol (2008) 0.89
Improving imaging diagnosis of persistent nodal metastases after definitive therapy for oropharyngeal carcinoma: specific signs for CT and best performance of combined criteria. AJNR Am J Neuroradiol (2013) 0.84
The role of SPET and PET in monitoring tumour response to therapy. Eur J Nucl Med Mol Imaging (2003) 0.84
Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment. Head Neck (2012) 0.83
PET in face and neck tumours. Cancer Imaging (2006) 0.83
Estimate of the impact of FDG-avidity on the dose required for head and neck radiotherapy local control. Radiother Oncol (2014) 0.83
Restricting carbohydrates to fight head and neck cancer-is this realistic? Cancer Biol Med (2014) 0.80
Concern Positron emission tomography in the detection of occult primary head and neck carcinoma: a retrospective study. Head Neck Oncol (2012) 0.80
PET/CT in Radiotherapy Planning for Head and Neck Cancer. Front Oncol (2012) 0.78
The role of PET/CT in the management of patients affected by head and neck tumors: a review of the literature. Eur Arch Otorhinolaryngol (2015) 0.77
Early assessment of radiation response using a novel functional imaging modality -- [18F]fluorocholine PET (FCH-PET): a pilot study. Discov Med (2012) 0.76
Predicting the Response of Neoadjuvant Therapy for Patients with Esophageal Carcinoma: an In-depth Literature Review. J Cancer (2015) 0.76
(18)F-FDG PET/CT quantification in head and neck squamous cell cancer: principles, technical issues and clinical applications. Eur J Nucl Med Mol Imaging (2016) 0.76
Does Metastatic Lymph Node SUVmax Predict Survival in Patients with Esophageal Cancer? Mol Imaging Radionucl Ther (2015) 0.75
Post-treatment appearances, pitfalls, and patterns of failure in head and neck cancer on FDG PET/CT imaging. Indian J Nucl Med (2014) 0.75
Lesion regression rate based on RECIST: prediction of treatment outcome in patients with head and neck cancer treated with chemoradiotherapy compared with FDG PET-CT. J Radiat Res (2015) 0.75
Comparison of PET/CT with conventional imaging modalities (USG, CECT) in evaluation of N0 neck in head and neck squamous cell carcinoma. Med J Armed Forces India (2012) 0.75
False Positive Positron Emission Tomography / Computed Tomography Scans in Treated Head and Neck Cancers. Cureus (2017) 0.75
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA (2000) 12.27
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63
Probability of stroke: a risk profile from the Framingham Study. Stroke (1991) 10.14
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol (1997) 6.10
Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med (2001) 5.68
The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. Arch Neurol (2000) 4.77
Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med (1994) 4.74
Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med (1995) 4.36
Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med (1993) 4.30
A predictive instrument to improve coronary-care-unit admission practices in acute ischemic heart disease. A prospective multicenter clinical trial. N Engl J Med (1984) 4.29
Stroke severity in atrial fibrillation. The Framingham Study. Stroke (1996) 4.11
Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation (1995) 4.04
Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med (1990) 3.99
Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis (2000) 3.81
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med (1998) 3.79
Variability of body weight and health outcomes in the Framingham population. N Engl J Med (1991) 3.61
Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA (1987) 3.59
Psychological predictors of hypertension in the Framingham Study. Is there tension in hypertension? JAMA (1993) 3.42
Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord (2003) 3.23
Stroke risk profile, brain volume, and cognitive function: the Framingham Offspring Study. Neurology (2004) 2.97
The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk factors. Arch Otolaryngol Head Neck Surg (1993) 2.91
Profile for estimating risk of heart failure. Arch Intern Med (1999) 2.81
Mitral annular calcification and the risk of stroke in an elderly cohort. N Engl J Med (1992) 2.77
Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke (2001) 2.71
Maximum likelihood estimation for interval-censored data using a Weibull-based accelerated failure time model. Biometrics (1992) 2.70
Clustering of metabolic factors and coronary heart disease. Arch Intern Med (1999) 2.69
Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA (1988) 2.68
Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol (1993) 2.67
Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology (1992) 2.64
Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. Stat Med (1988) 2.62
Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol (2001) 2.57
Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. Stat Med (2000) 2.54
Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med (1999) 2.53
Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument. Ann Intern Med (1997) 2.52
Evaluation of subsecond gated helical CT for quantification of coronary artery calcium and comparison with electron beam CT. AJR Am J Roentgenol (2000) 2.49
Secular trends in the prevalence of atrial fibrillation: The Framingham Study. Am Heart J (1996) 2.47
Significance of node biopsy before definitive treatment of cervical metastatic carcinoma. Laryngoscope (1978) 2.45
Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study. Neurology (1997) 2.43
The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Arch Neurol (1995) 2.42
Missed diagnoses of acute myocardial infarction in the emergency department: results from a multicenter study. Ann Emerg Med (1993) 2.39
Sudden coronary death in women. Am Heart J (1998) 2.33
Intermittent claudication. A risk profile from The Framingham Heart Study. Circulation (1997) 2.29
Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology (1993) 2.21
Functional limitations and disability among elders in the Framingham Study. Am J Public Health (1992) 2.17
Genetic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr (2007) 2.10
Predictors of smoking cessation: the Framingham Study. Am J Epidemiol (1992) 2.09
Secular trends in stroke incidence and mortality. The Framingham Study. Stroke (1992) 2.07
Prehospital advanced life support: benefits in trauma. J Trauma (1984) 2.00
Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J (1993) 1.96
Iron status of the free-living, elderly Framingham Heart Study cohort: an iron-replete population with a high prevalence of elevated iron stores. Am J Clin Nutr (2001) 1.92
NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care (1997) 1.89
Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes (1997) 1.88
Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation (1994) 1.86
Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med (1999) 1.86
Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA (2000) 1.83
Placebo-associated blood pressure response and adverse effects in the treatment of hypertension: observations from a Department of Veterans Affairs Cooperative Study. Arch Intern Med (2000) 1.77
Validation of a dietary pattern approach for evaluating nutritional risk: the Framingham Nutrition Studies. J Am Diet Assoc (2001) 1.76
Predicting mortality in nursing home residents with lower respiratory tract infection: The Missouri LRI Study. JAMA (2001) 1.74
Coherent global motion percepts from stochastic local motions. Vision Res (1984) 1.72
Association of blood pressure with fibrinolytic potential in the Framingham offspring population. Circulation (2000) 1.70
Pituitary gland: MR imaging of physiologic hypertrophy in adolescence. Radiology (1990) 1.68
Blood pressure as a risk factor for cardiovascular disease. The Framingham Study--30 years of follow-up. Hypertension (1989) 1.64
Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care (2001) 1.63
Hemostatic state and atrial fibrillation (the Framingham Offspring Study). Am J Cardiol (2001) 1.63
Dietary lipid predictors of coronary heart disease in men. The Framingham Study. Arch Intern Med (1991) 1.63
Body fat distribution and breast cancer in the Framingham Study. J Natl Cancer Inst (1990) 1.60
Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): The NIDDM Patient Outcome Research Team. Am J Med (1997) 1.59
An outcome audit of the treatment of acute dentoalveolar infection: impact of penicillin resistance. Br Dent J (2005) 1.59
G-estimation of causal effects: isolated systolic hypertension and cardiovascular death in the Framingham Heart Study. Am J Epidemiol (1998) 1.59
Spontaneous pneumomediastinum: evaluation and treatment. J Fam Pract (1990) 1.58
Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study. Diabetes (1996) 1.53
Aortic calcified plaques and cardiovascular disease (the Framingham Study). Am J Cardiol (1990) 1.53
Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med (1999) 1.51
Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer (1994) 1.51
Pannexin1 hemichannels are critical for HIV infection of human primary CD4+ T lymphocytes. J Leukoc Biol (2013) 1.51
Can sustained weight loss in overweight individuals reduce the risk of diabetes mellitus? Epidemiology (2000) 1.50
A technique for summarizing longitudinal data. Stat Med (1993) 1.49
High intraocular pressure and survival: the Framingham Studies. Am J Ophthalmol (1999) 1.49
Can positron emission tomography distinguish tumor recurrence from irradiation sequelae in patients treated for larynx cancer? Cancer J Sci Am (1998) 1.49
Effect of weight on cardiovascular disease. Am J Clin Nutr (1996) 1.47
Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. The Framingham Heart Study 1950 to 1990. Circulation (1996) 1.47
Applicability of cholesterol-lowering primary prevention trials to a general population: the framingham heart study. Arch Intern Med (2001) 1.46
The usefulness of a predictive instrument to reduce inappropriate admissions to the coronary care unit. Ann Intern Med (1980) 1.45
CT and MR imaging of nonaccidental pediatric head trauma. Acad Radiol (1998) 1.45
The Roberts syndrome. Clin Genet (1974) 1.45
Precursors of extracranial carotid atherosclerosis in the Framingham Study. Neurology (1994) 1.45
A pilot study of bioaerosol reduction using an air cleaning system during dental procedures. Br Dent J (2010) 1.44
Use of brain biopsy for diagnostic evaluation of patients with suspected herpes simplex encephalitis: a statistical model and its clinical implications. NIAID Collaborative Antiviral Study Group. J Infect Dis (1991) 1.44